Efficacy Of Brodalumab In Total Clearance Of Nail Unit Psoriasis

Boni Elewski,Phoebe Rich,George Han,Richard K. Scher,Abby Jacobson

Journal of The American Academy of Dermatology（2020）

引用 0|浏览0

暂无评分

摘要

Background: Brodalumab is a fully human anti–interleukin-17 receptor A antagonist efficacious in treating moderate to severe plaque psoriasis. We evaluated the efficacy of brodalumab in patients with nail unit psoriasis in 2 randomized clinical trials (AMAGINE-2/-3), as measured by complete nail clearance.

查看译文

关键词

nail unit psoriasis,brodalumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要